NCT02957604View on ClinicalTrials.gov

Evolocumab Pregnancy Exposure Registry

TerminatedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

December 22, 2016

Primary Completion Date

September 2, 2020

Study Completion Date

September 2, 2020

Conditions
Hypercholesterolemia; ASCVD; Pregnancy
Interventions
DRUG

evolocumab

Pregnant women exposed to evolocumab. Evolocumab is not administered in this non-interventional study.

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
collaborator

Organization of Teratology Information Specialists (OTIS) Research Center - tel: 1-866-626-6847 or www.mothertobaby.org

UNKNOWN

lead

Amgen

INDUSTRY

NCT02957604 - Evolocumab Pregnancy Exposure Registry | Biotech Hunter | Biotech Hunter